A diastereoselective synthesis of boceprevir's gem-dimethyl bicyclic [3.1.0] proline intermediate from an insecticide ingredient cis-cypermethric acid-Reference-Cited by-同舟云学术

A diastereoselective synthesis of boceprevir's gem-dimethyl bicyclic [3.1.0] proline intermediate from an insecticide ingredient cis-cypermethric acid

Published:2017-07 Issue:30 Volume:73 Page:4285-4294
ISSN:0040-4020
Container-title:Tetrahedron
language:en
Short-container-title:Tetrahedron

Author:

Kallam Srinivasa Reddy,Eda Vishnuvardhan Reddy,Sen Saikat,Datrika Rajender,Rapolu Rajesh Kumar,Khobare Sandip,Gajare Vikas,Banda Malavika,Khan Rashid Abdul Rehman,Singh Manpreet,Lloyd Michael,Kandagatla Bhaskar,Janagili Moses Babu,Tadikonda Veerabhadra Pratap,Vidavalur Siddaiah,Iqbal Javed,Fox Martin E.,Dahanukar Vilas H.,Oruganti Srinivas

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Reference35 articles.

1. Therapeutics: New drugs hit the target

2. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

3. World Health Organization (WHO). Hepatitis C. Fact Sheet No. 164. http://www.who.int/mediacentre/factsheets/fs164/en/ (revised on July 2016).

4. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

5. Introduction: A smouldering public-health crisis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Gem-Dimethyl Bicyclic [3.1.0] Proline as an Antiviral Drug Intermediate;Mini-Reviews in Organic Chemistry;2024-04-29

2. The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19;Pharmaceutics;2024-02-02

3. Molecules for COVID-19 treatment;Chinese Chemical Letters;2023-12

4. Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug;Tetrahedron Letters;2023-02

5. Development and patent synthesis of nirmatrelvir – the main component of the first oral drug against SARS-CoV-2 Paxlovid;Australian Journal of Chemistry;2022-08-18